Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. Financials
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 94 860132 331131 461168 712--
Entreprise Value (EV)2 109 142144 340143 328193 600190 017184 646
P/E ratio 44,0x97,9x41,0x40,3x21,9x16,6x
Yield 3,74%2,78%2,80%2,58%2,66%2,79%
Capitalization / Revenue 4,29x5,43x4,94x4,70x3,91x3,60x
EV / Revenue 4,94x5,92x5,38x5,39x4,40x3,94x
EV / EBITDA 15,3x21,6x17,2x17,6x12,1x9,96x
Price to Book 7,61x10,00x8,41x3,93x3,95x3,53x
Nbr of stocks (in thousands) 1 266 8121 311 9131 312 6601 549 159--
Reference price (USD) 74,9101100109109109
Announcement Date 02/14/201902/14/202002/11/2021---
1 GBP in Million
2 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 22 09024 38426 61735 92643 14346 854
EBITDA1 7 1406 6868 31111 01415 71118 535
Operating profit (EBIT)1 5 6726 4367 34010 04814 22816 816
Operating Margin 25,7%26,4%27,6%28,0%33,0%35,9%
Pre-Tax Profit (EBT)1 1 9931 5483 9162 6387 55610 306
Net income1 2 1551 3353 1962 7247 0699 344
Net margin 9,76%5,47%12,0%7,58%16,4%19,9%
EPS2 1,701,032,442,704,976,58
Dividend per Share2 2,802,802,802,812,893,04
Announcement Date 02/14/201902/14/202002/11/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 7 3208 2209 86610 9789 89810 618
EBITDA1 2 6921 8801 1144 4013 6243 902
Operating profit (EBIT)1 2 5241 8052 2813 295--
Operating Margin 34,5%22,0%23,1%30,0%--
Pre-Tax Profit (EBT)1 1 608764-2 0011 769--
Net income1 1 561550-1 6521 666--
Net margin 21,3%6,69%-16,7%15,2%--
EPS2 1,190,42-1,100,760,440,62
Dividend per Share ------
Announcement Date 04/30/202107/29/202111/12/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 14 28212 00911 86724 88821 30515 935
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,00x1,80x1,43x2,26x1,36x0,86x
Free Cash Flow1 1 5751 9903 8384 1508 78811 015
ROE (Net Profit / Equities) 32,0%35,6%36,7%24,2%24,7%28,0%
Shareholders' equity1 6 7423 7528 70411 26728 63633 360
ROA (Net Profit / Asset) 7,07%2,19%4,99%6,98%9,20%10,9%
Assets1 30 48061 01564 05339 03976 82485 434
Book Value Per Share2 9,8410,111,927,727,630,9
Cash Flow per Share2 2,072,283,664,817,868,92
Capex1 1 0439799611 6992 0302 018
Capex / Sales 4,72%4,01%3,61%4,73%4,70%4,31%
Announcement Date 02/14/201902/14/202002/11/2021---
1 USD in Million
2 USD
Analysis
Officials offer vaccine reassurance; WHO advises against travel bans
Key data
Capitalization (GBP) 127 387 341 609
Capitalization (USD) 168 441 616 895
Net sales (USD) 26 617 000 000
Number of employees 76 100
Sales / Employee (USD) 349 763
Free-Float 96,4%
Free-Float capitalization (GBP) 122 764 946 619
Free-Float capitalization (USD) 162 329 520 699
Avg. Exchange 20 sessions (USD) 16 880 762 071
Average Daily Capital Traded 13,3%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA